A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients

A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients

Sponsors and Collaborators
Washington University School of Medicine
National Institutes of Health (NIH)

Contact
Farley Johnson, M.A, B.A., CCRP     
314-747-9202     
[email protected]

Kirsten Cady, B.S., CCRP     
314-362-7773     
[email protected]

Investigators
William E. Gillanders, M.D.     
Washington University School of Medicine

ClinicalTrials.gov Identifier
NCT00355316